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Abstract
Background: Interpreting proteomic and genomic data is a major challenge in predictive ecotoxicology that can
be addressed by a systems biology approach. Mathematical modeling provides an organizational platform to
consolidate protein dynamics with possible genomic regulation. Here, a model of ovarian steroidogenesis in the
fathead minnow, Pimephales promelas, (FHM) is developed to evaluate possible transcriptional regulation of steroid
production observed in microarray studies.
Results: The model was developed from literature sources, integrating key signaling components (G-protein and
PKA activation) with their ensuing effect on steroid production. The model properly predicted trajectory behavior
of estradiol and testosterone when fish were exposed to fadrozole, a specific aromatase inhibitor, but failed to
predict the steroid hormone behavior occurring one week post-exposure as well as the increase in steroid levels
when the stressor was removed. In vivo microarray data implicated three modes of regulation which may account
for over-production of steroids during a depuration phase (when the stressor is removed): P450 enzyme up-
regulation, inhibin down-regulation, and luteinizing hormone receptor up-regulation. Simulation studies and
sensitivity analysis were used to evaluate each case as possible source of compensation to endocrine stress.
Conclusions: Simulation studies of the testosterone and estradiol response to regulation observed in microarray
data supported the hypothesis that the FHM steroidogenesis network compensated for endocrine stress by
modulating the sensitivity of the ovarian network to global cues coming from the hypothalamus and pituitary.
Model predictions of luteinizing hormone receptor regulation were consistent with depuration and in vitro data.
These results challenge the traditional approach to network elucidation in systems biology. Generally, the most
sensitive interactions in a network are targeted for further elucidation but microarray evidence shows that
homeostatic regulation of the steroidogenic network is likely maintained by a mildly sensitive interaction. We
hypothesize that effective network elucidation must consider both the sensitivity of the target as well as the
target’s robustness to biological noise (in this case, to cross-talk) when identifying possible points of regulation.
Background
Recently, the field of toxicology has begun to shift from
an observational study of disease-specific models in vivo
to a more predictive science focusing on mechanism-
based, biological observations in vitro using high
throughput technologies [1]. This transition was
prompted by the increasingly large number of substances
needing to be tested, the need to better relate to human
and animal data, and the overall expense of disease-
specific studies [1-3]. A specific challenge in toxicology is
the ability to identify or predict compensatory responses
that occur in response to trace levels of poison exposure
[4]. These challenges are best addressed using systems
approaches which focus on organizing and exploring the
complex networks affected during toxin exposure and
response. High-throughput technologies such as microar-
rays can observe the global response of the genome
under various conditions, but several challenges remain
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teomic and genomic behaviors can differ between in vitro
and in vivo data sets as inter-organ regulation is
removed. Mathematical models provide organizational
platforms to generate hypotheses that allow for consis-
tency while interpreting these heterogeneous data sets.
Aspects of biological networks, such as robustness,
can be exploited to guide network elucidation [6,7] and
reveal pathways critical to the body’sr e s p o n s et ot o x i n
exposure. Robustness, the ability of a biological network
to maintain performance under variable environmental
conditions, is an emergent system property often
employed to guide model development/reduction [8].
Robustness can be observed at many levels of complex-
ity. Considering viability as a performance measure,
mutation studies in yeast [9], flies [10], and mice [11]
find that these organisms are robust to single gene dele-
tions in 80-90% of the genome. Robustness properties
have been explored in several systems, such as circadian
gene regulatory networks [12], chemotaxis [13], and
apoptosis [14,15]. For systems described by ordinary dif-
ferential equations, sensitivity analysis can identify inter-
actions or species (i.e., genes or proteins) which most
strongly dictate the behavior of the network output [16],
ultimately guiding the next iteration of experimentation
and model development.
Sensitivity is the network response to infinitesimal dis-
turbances in either a parameter value or initial condi-
tion. It is a dynamic measure (evaluated over time)
which can identify optimal experimental conditions and
guide model reduction [17]. Bentele et al. applied sensi-
tivity analysis to reduce system complexity in a CD95
induced apoptosis model [14]. Applied to circadian
rhythm models, sensitivity analysis shows that circadian
systems are often more fragile to perturbations in global
parameters (transcriptional and translational machinery)
than local parameters, a characteristic which appears to
be the result of network topology as opposed to para-
meter tuning [12,18]. Sensitivity analysis is often
embedded in design of experiment schemes to identify
network interactions which best manipulate the observa-
ble outputs [19].
In this work, a model of ovarian steroidogenesis in the
fathead minnow (Pimephales promelas, FHM) is devel-
oped to consolidate mRNA and protein data. Steroido-
genesis, the production of hormones from cholesterol, is
essential to a wide range of physiological and pathologi-
cal processes [20]. Hormones are powerful physiological
regulators, allowing organs to induce changes in distant
tissues within the organism. Testosterone (T) and estro-
gens, such as estrone (E1)a n de s t r a d i o l( E 2), serve as
growth hormones for reproductive tissues whose regula-
tion is essential to reproduction as well as several other
physiological factors such as bone structure [21] and
arterial blood flow [22]. On the pathological side, endo-
crine inhibiting therapies such as fadrozole (FAD), a
specific aromatase inhibitor, are commonly used to slow
the progression of estrogen-dependent breast cancers
[23]. These hormones are primarily produced in the
gonads through a series of enzyme-mediated reactions
[24]. Cholesterol availability is regulated by gonadotro-
pin-releasing hormone (GnRH) and luteinizing hormone
(LH), which are released from hypothalamic and pitui-
tary tissues, respectively and activate a series of signaling
events, ultimately resulting in the production of StAR
protein [25,26]. StAR protein facilitates the translocation
of cholesterol in the theca cells of the ovary from the
outer to the inner mitochondrial membrane, the first
step in steroidogenesis (See Figure 1) [27].
Hormone regulation is highly sensitive to endocrine-
disrupting compounds (EDCs) released into the environ-
ment [4]. EDCs are an environmental health concern as
they are potentially hazardous at trace concentrations.
The industrial chemical bisphenol A (BPA), used to
manufacture polycarbonate plastics, may leach from dis-
posable plastic bottles. Leached BPA can act as an estro-
gen receptor modulator linked to a variety of issues
during early development [28]. Ketoconazole, found in
antifungal ointments, and ethinyl estradiol, the active
ingredient in most oral birth control pills, both inhibit
different aspects of the enzyme machinery essential to
the conversion of cholesterol to steroids [29,30]. Since
they also affect systems involved in development, expo-
sure effects may not be immediately apparent until
many years post-exposure [4]. Mathematical models that
can assist in identifying genomic and metabolic signa-
t u r e sf o rE D Ce x p o s u r e s ,a sw e l la sp r e d i c t i n gt h e
effects of EDCs would be especially valuable for under-
standing the health risk of chemicals in the
environment.
T h eF H Mi sw i d e l yu s e db yt h eU SE n v i r o n m e n t a l
Protection Agency as an ecological test organism due to
its wide distribution throughout North America, avail-
ability, and relatively short generation time [31]. Wata-
nabe et al. [32] developed a physiologically-based
computational model of steroidogenesis in the male
FHM to describe the effects of E2 and ethinyl estradiol
(EE2) exposure. While the model accurately described
the impacts of these two chemicals on steroid produc-
tion, it did not incorporate many of the key signaling
pathways that might influence the response of FHM to
a variety of EDCs.
To better understand the regulatory response of the
steroidogenesis pathway to EDC exposure, a signaling
model composed of ordinary differential equations was
created to predict the effects of exposure to the aroma-
tase inhibitor fadrozole (FAD) on FHM steroidogenesis.
We incorporated into the model key signaling pathways
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literature. As the steroidogenesis pathway is considered
highly conserved among a variety of species [33], the
model of ovarian steroidogenesis was constructed by
integrating several mouse and fish models currently
available in the literature. We used microarray data
from an in vivo and in vitro exposure to FAD to detect
potential key signaling pathways involved in steroido-
genesis, such as G-protein signaling, kinase activity, and
mitochondrial transport. A graphical FHM steroidogen-
esis model [25] was combined with G protein cycling
and protein kinase A (PKA) activation models [34].
These models quantify the intra-ovary signaling which
regulates steroidogenic acute regulatory (StAR) gene
activation, which in turn regulates the transport of
cholesterol into the inner mitochondrial membrane [27].
Once in the mitochondria, steroid production is
described by a model of the enzyme-mediated conver-
sion of cholesterol to its steroid derivatives [24]. Extra-
ovary signaling occurring along the hypothalamus-pitui-
tary-gonadal (HPG) axis was incorporated using the reg-
ulatory effects of E 2 and T on the production of
luteinizing hormone (LH) described by Watanabe et al.
[32]. We tested our model using data from a new expo-
sure. Fish were exposed to two different concentrations
of FAD for eight days, then the chemical was removed
and samples were taken for eight more days. Steroid
levels were measured. Our model was able to predict
the steroid response to the FAD but failed to capture
the apparent compensation (in terms of T and E2 serum
Figure 1 Model of sex steroid production in ovaries. Cholesterol transport within ovarian cells is modulated by the feedback of E2 and T on
LH production in the brain and pituitary. These effects are summarized by the Signal Modulation compartment of the model. When LH binds its
receptor, it activates G protein recycling and the activation of adenylate cyclase. This produces the necessary cAMP for PKA and
phosphodiesterase activation. The signaling cascade ends at the activation of StAR which allows for the translocation of cholesterol into the
mitochondria. Once in the mitochondria, cholesterol goes through a series of enzyme-mediated reactions to produce sex steroids.
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over compensation observed during the depuration
phase. Sensitivity analysis and microarray data identified
possible missing regulation steps that could be responsi-
ble for the over production of these steroids during
depuration.
Results
Steroidogenesis model development
To consolidate the steroidogenic response between in
vivo and in vitro steroid measurements, a G protein sig-
naling model [34] and a model of intra-mitochondrial,
enzyme-mediated steroidogenesis [24] were coupled
with a mathematical description of LH production.
Microarray data from FAD exposures identified mito-
chondrial transport and G-protein signaling as enriched
Gene Ontology (GO) terms. Microarrays also identified
many differentially expressed genes related to kinase
activity and adenylate cyclase both in the in vivo and in
vitro exposure. Due to their close relation to steroido-
genesis confirmed by the microarrays, the pathways
were incorporated into the model.
LH hormone, produced in the pituitary, is regulated
by gonadotropin-releasing hormone (GnRH) released
from the hypothalamus [35]. GnRH is released in a pul-
satile fashion and the frequency is dependent on several
physiological factors [36]. While GnRH dynamics lead
to pulsatile LH levels, the magnitude of the oscillations
is thoroughly damped by the G-protein signaling
process.
LH binds to its receptor, initiating the first step in the
G-protein cycle (Figure 1). The original model of G pro-
tein cycling, and its ensuing activation of adenylate
cyclase/protein kinase A production by Hao et al.
described the binding of vasoactive intestinal polypep-
tide (VIP) and CREB activation. While receptor/ligand
binding rates may differ between the VIP system and
steroidogenesis, the two systems share the same signal-
ing architecture, namely adenylate synthetase (AD) acti-
vation, protein kinase A (PKA) activation and
phosphodiesterase activation. Thus, the description
applied to VIP concentration/CREB activation is applied
to LH/SF1 activation (See the Methods section for
greater detail on individual reaction steps).
The activation of SF1 promotes the transcription of
StAR. The StAR protein is the primary transporter of
cholesterol across the mitochondrial membrane, the
rate-limiting step of steroid production [37]. Once in
the inner mitochondrial membrane, cholesterol is trans-
formed by a series of enzyme-catalyzed reactions, pri-
marily from the cytochrome P450 oxidase enzyme
family. Breen et al. [24] first modeled the steps between
cholesterol and T/E2 production, and applied the model
to describe steroid production in ovary explants exposed
to FAD. Four steroids are produced (androstenedione
(AD) and estrone (E1) are produced as well), but E2 and
T are known to inhibit the transcription of LH. Detailed
models of the pituitary and hypothalamus are unavail-
able, thus LH transcription and translation were
described by a set of reactions labeled as Signal Modula-
tion (See Figure 1). This strategy reduces the complexity
in both the visualization and mathematical modeling of
steroidogenesis while still capturing the feedback regula-
tion of steroid production on LH levels.
Parameter Training
While the majority of parameters have been justified in
their original publications, measurements are unavailable
for parameters related to LH transcription and its inhi-
bition. These parameters were used to train the system
to a training data set, and the resulting model was eval-
uated for both predictive capacity and sensitivity to
parameter uncertainty. Given the small number of para-
meters which required fitting, parameters were operator
tuned. Figure 2 shows the fitted response of the steroi-
dogenesis model to T and E2 measurements taken from
ovaries (ex vivo) stressed with 50 g FAD/L for 6, 12,
and 24 h. The model performed well with the exception
o ft h e6ht i m ep o i n tw h e r ep r o d u c t i o no fTi s
overestimated.
Sensitivity Analysis
To evaluate the sensitivity of the resulting model fitting,
the relative sensitivity of the steroidogenesis model was
calculated for each state to each parameter, averaged
over time (Figure 3). The parameters clustered into var-
ious ranges of sensitivity. The most sensitive parameters
was generally in the PKA activation cycle (states 16 -
21) and included some interactions outside of the PKA
cycle itself, such as basal G-protein activation (para-
meter 22) and AC activation (parameters 17 - 19). Cho-
lesterol and steroid states (states 39, 44-56) were most
s e n s i t i v et op a r a m e t e r s5 4-5 7 ,6 0-6 4 ,a n d7 1-7 4 ,
which corresponded to PKA inhibition, PKA transloca-
tion and the rate of protein synthesis, respectively.
We perturbed the nominal parameter set over 1000
parameter generations to determine the robustness of
the sensitivity analysis conclusions to the nominal para-
meter values selected (Figure 4). When all states were
considered equal (the relative sensitivity of all states was
averaged together), the sensitivity results above
remained true. It can be stated with confidence that the
steroidogenesis network is very sensitive to noise in the
G-protein and PKA activation cycles. Focusing specifi-
cally on the sensitivity of steroid trajectories (Figure 4,
bottom), the significance of noise within the PKA and
G-protein cycles was reduced. In general, only interac-
tions specific to SF1 activation and StAR transcription
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sitivity was averaged over all states or restricted to ster-
oid production, steroidogenesis was only mildly sensitive
due to uncertainty in T/E2 feedback and LH production
(parameter numbers 84 - 93). Thus, uncertainty in the
operator tuned parameters should have minimal effect
on steroidogenic behavior.
General behavior of the Steroidogenesis Model
Several qualitative characteristics of LH signaling and
steroid production were accurately captured by this
mathematical description. Oscillatory dynamics imposed
by the GnRH description was evident in the highly oscil-
latory behavior of proteins that were between the LH
and SF1 activation (See Figure 5). The mean concentra-
tion and amplitude of the LH concentration was consis-
tent with levels observed in mammals [38]. The
magnitude of the oscillations was damped when the
signal reached SF1 activation, and near fully damped at
the level of StAR protein production. No significant
oscillations were observable in the steroid concentra-
tions. As FAD was introduced in the model, the E2 con-
centration in the blood stream was reduced. T in the
blood stream was elevated during FAD exposure. The
steady state concentration of T rises monotonically with
FAD exposure level.
Model Predictions of Steroid Dynamics
The model predictions of T and E2 were compared to
published effects of FAD on E2 steroid production by
ovaries in ex vivo assays [39]. Villeneuve et al [39]
exposed FHM to 0, 3.0, or 30 μgF A D / Li na q u a r i aa n d
examined the impact of FAD on E2 and T production
during 8 days of exposure and a subsequent 8 days of
depuration (Figure 6). Behavior of mean levels of E2
were well predicted for all time points through 4 days of
Figure 2 The fitted model trajectories of E2 and T concentration of during to 50 μg FAD/L (red) ex vivo. FAD was introduced into the
media, and the fish were exposed for 6, 12, and 24 hours. At each time point, fish were removed from the media and ex vivo production of T
and E2 ovaries measured. Upper triangles represent control measurements while open circles represent exposure measurements. Model
predictions are shown in solid black and red lines for control and FAD exposed data, respectively.
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ent compensation occurring at day 8 of FAD exposure
nor the subsequent over compensation of the steroido-
genesis network after the stressor is removed. With the
exception of day 4, the model was generally capable of
predicting the mean levels of T production at 3 and 30
μgF A D / Ld u r i n g8de x p o s u r e ,b u t ,a g a i n ,t h em o d e l
did not predict the overcompensation after stressor
removal. At low levels of FAD (3 μg/L), T levels were
not significantly different from controls due to sample
variability.
Microarray results
Global microarray expression analysis of in vivo and in
vitro (ovary slices) tissues exposed to FAD revealed sig-
nificantly different responses. Genes identified as differ-
entially expressed (P < 0.05) within each treatment
(FAD in vivo and in vitro) are listed in Additional
File 1. In general, significantly more genes were affected
in vivo than in vitro. When genes were filtered for those
with 1.5-fold change or greate r ,i nv i t r oF A De x p o s u r e
resulted in 104 genes up regulated and 169 down regu-
lated, whereas in vivo exposure resulted in 298 up regu-
lated and 267 down regulated. Only 34 genes were
common between the two exposures, suggesting that
the steroidogenesis regulation involved in each system is
very different when comparing ovary tissue to whole
fish regulation.
To determine whether particular biological processes
were enhanced or decreased in either exposure scenario,
we calculated the over-representation of specific biologi-
cal processes in the selected gene list. Ovaries exposed
to FAD in vitro had 1 up- regulated and 24 down- regu-
lated biological processes (including redundant cate-
gories) (P < 0.05), whereas in vivo exposures to FAD
had 17 and 58 categories up- and down-regulated,
respectively (P < 0.05) (Table 1).
In the FAD in vitro exposure (Table 1), epithelium
morphogenesis, mitochondrial transport and protein
amino acid glycosylation were among the most affected
Figure 3 The relative sensitivity of each state to each parameter, averaged over time. The sensitivity was calculated over a span of 30
days, and color bars represent the value of the relative sensitivity for each state to each parameter.
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Page 6 of 17Figure 4 The average relative sensitivity (ARS) for each parameter and state was calculated over time for 1000 parameter generations.
Sensitivity was then averaged over all states and time for each parameter and its boxplot is shown to illustrate the sensitivity distribution.
Figure 5 The response of the steroidogenesis model to increasing FAD exposure. GnRH introduces a pulse affect on LH. The oscillatory
behavior at the LH receptor is filtered by the G-protein and PKA cycles and is significantly minimized by the time the signal reaches SF1. The
cholesterol pool available inside the mitochondria is suppressed by FAD exposure. This leads to suppression of E2 and over production of T in
the blood stream.
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development, mitochondrial transport, carbohydrate-
glucose metabolism, gastrulation and potassium trans-
port were the most affected.
For the FAD in vivo exposure, among the most
affected biological processes we found were skeletal-tis-
sue remodeling-ossification pathways, purine nucleotide
biosynthesis - deoxyribonucleotide metabolism, and
oogenesis. Up-regulated biological processes were: skele-
tal- tissue remodeling - ossification (consistent with acti-
vation of the bone morphogenesis protein signaling
pathways -and up regulation of Activin Receptor) and
amino acid transport processes. Down were signal
transduction - G-protein signaling, coupled to cAMP
nucleotide second messenger, nucleotide -ATP bio-
synthesis, programmed cell death - anti-apoptosis, and
pregnancy related processes.
Predictions of observed genome regulation on steroid
concentrations
Additional regulations observed in microarray data were
simulated to predict the transcriptional regulation effects
on protein behavior. It is assumed that up regulation of
LH receptor results in a greater concentration of recep-
tors, thus making the ovary cells more sensitive to the
LH input, and resulting in an over-production of E2 and
Figure 6 Model predictions of FAD effects on E2 and T production over extended periods. For 8 days, fish were exposed to 3 and 30 μg/
L FAD. After the 8
th day FAD was flushed from the aquaria with fresh water. Fish continued to be sampled for 8 days to measure T and E2
during depuration. Data is shown in an upper triangle, open circle, and lower triangle for the control, 3, and 30 μg/L FAD exposures,
respectively. The corresponding model predictions are solid black, dashed red, and dashed blue. Data from [39].
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obtained when the maximal rate of LH transcription
was perturbed upwards. Perturbing concentrations of
cytochrome P450-17ahydroxylase/17,20-lyase, identified
as up-regulated in microarray data, had no observable
affect on chol, T, or E2 dynamics (Figure 7B). The same
is true of inhibin down-regulation (Figure 7C). All three
possible transcriptional regulations were tested for
possible synergistic effects, but none was observed.
Discussion
The general approach to discerning stress response sig-
natures in environmental toxicology is disease-specific
and often based on the limited observations available.
As more physiologically active compounds enter the
environment, it becomes necessary to develop effective
techniques to catalogue previous observations so as to
extrapolate and predict the effects of new compounds.
Mathematical models organize previous observations to
Table 1 Functional analysis of genes differentially expressed in ovaries during 24 hr fadrozole exposure
ENRICHED GO TERMS UP-REGULATED FOR FAD IN VITRO ENRICHED GO TERMS UP-REGULATED FOR FAD IN VIVO
GO Name p Value GO Name p Value
morphogenesis of an epithelium 0.011 pregnancy 0.009
protein amino acid glycosylation 0.029 ossification 0.012
glycoprotein biosynthesis 0.033 regulation of cell growth 0.012
biopolymer glycosylation 0.034 amino acid derivative catabolism 0.020
embryonic development (sensu Metazoa) 0.046 tissue development 0.021
glycoprotein metabolism 0.046 anti-apoptosis 0.027
cell differentiation 0.029
osteoblast differentiation 0.031
development 0.036
oogenesis 0.042
reproductive physiological process 0.043
nucleoside triphosphate metabolism 0.044
ENRICHED GO TERMS DOWN-REGULATED FOR FAD IN VITRO ENRICHED GO TERMS DOWN-REGULATED FOR FAD IN VIVO
GO Name p Value GO Name p Value
gastrulation 0.008 negative regulation of apoptosis 0.002
DNA replication 0.009 anti-apoptosis 0.003
cellular carbohydrate metabolism 0.016 negative regulation of programmed cell death 0.003
carbohydrate metabolism 0.019 purine ribonucleotide biosynthesis 0.004
potassium ion transport 0.021 pregnancy 0.006
macromolecule biosynthesis 0.023 nucleoside triphosphate metabolism 0.007
glucose catabolism 0.025 transcription from RNA polymerase II promoter 0.009
hexose catabolism 0.026 regulation of physiological process 0.012
monosaccharide catabolism 0.026 signal transduction 0.013
positive regulation of cellular process 0.026 purine nucleoside triphosphate biosynthesis 0.015
alcohol catabolism 0.027 nucleoside triphosphate biosynthesis 0.016
physiological process 0.028 G-protein signaling, coupled to cyclic nucleotide second messenger 0.020
energy derivation by oxidation of organic compounds 0.032 reproductive organismal physiological process 0.021
mitochondrial transport 0.033 nucleoside metabolism 0.024
positive regulation of biological process 0.035 reproductive physiological process 0.024
glucose metabolism 0.036 energy coupled proton transport, down electrochemical gradient 0.024
protein amino acid glycosylation 0.040 ATP synthesis coupled proton transport 0.024
muscle contraction 0.042 regulation of cellular physiological process 0.026
protein biosynthesis 0.043 cell-cell adhesion 0.027
glycoprotein biosynthesis 0.044 cell proliferation 0.031
carbohydrate catabolism 0.044 regulation of programmed cell death 0.038
cellular carbohydrate catabolism 0.044 apoptosis 0.038
biopolymer glycosylation 0.045 G-protein signaling, coupled to cAMP nucleotide second messenger 0.038
cellular process 0.046 development 0.040
**The full list of significant GO terms are in Additional File 1.
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mathematical model was developed from literature and
tested to predict steroid behavior during EDC exposure.
The model then consolidated steroid dynamics observed
during depuration with possible regulatory mechanisms
identified via microarrays.
We developed the FHM female steroidogenesis model
by merging G-proteins and PKA activation models with
the architecture of a graphical steroidogenesis model
[24,25,34,35]. The resulting model predicts several quali-
tative dynamics known to steroidogenesis (Figure 5). LH
and cholesterol availability are the drivers for steroido-
genesis. LH has pulsatile dynamics [35], which lead to
oscillatory behavior in the G protein, PKA, and AC acti-
vation cycles in the model. The magnitude of the oscil-
lations was suppressed as the steroidogenic signal
traveled from the LH receptor to the SF1 activation site.
They were further damped by the transcription and pro-
duction of StAR, and no significant oscillations were
observed in the steroid profiles. The oscillatory nature
of LH signaling and the lack of oscillations in steroid
concentrations have been measured in several studies,
providing qualitative support to the models validity
[24,35]. When inter-organ signaling was removed, the
model reduced to the Breen et al.[ 2 4 ]i nv i t r om o d e l
and was capable of reproducing in vitro steroid behavior
observed during FAD exposure.
The model was further validated by its ability to pre-
dict E2 and T dynamics in response to different degrees
of FAD stress. FAD is an ideal candidate for model
discrimination because it specifically inhibits the aroma-
tase activity responsible for converting E1 and T to E2
Figure 7 Microarray data suggests that missing regulation involving (A) LH receptor up regulation, (B) Cytochrome
P450c17ahydroxylase/17,20 lyase up regulation, or (C) inhibin down regulation may account for over production of T and E2 during
depuration. Each scenario was examined in the model by multiplying the appropriate parameter(s) with perturbations spanning three orders of
magnitude. Neither up regulating P450 enzyme nor down regulating inhibin translation affected T or E2 production. Up regulating the
translation of LH and/or increasing the available quantity of LH receptors both caused an increase in cholesterol translocation. This ultimately
resulted in an over production of both E2 and T when compared to an unexposed fish (control).
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can be suitably described. We monitored steroid pro-
d u c t i o ni nf i s he x p o s e dt o5 0μg/L FAD for 6, 12, and
24 hrs and used this data for parameter training (Figure
2). The predictive capacity of the resulting model was
validated against recently published data where FHM
were monitored during exposures to 3 and 30 μg/L
FAD for 8 days and a subsequent 8 day recovery period
after the removal of FAD [39]. Testing showed that the
model was capable of predicting steroid behavior to
lower FAD exposures better than that of the training
data (Figure 6). Model predictions and experimental
results began to deviate at the 8d exposure period, when
the steroidogenesis network appeared to start compen-
sating for the FAD stress. This compensation was
further revealed during depuration, when the network
overcompensated after the stressor had been removed.
Sensitivity analysis supported PKA activation as the
primary means of regulating the steroid response under
stress. The parameter belonging to the PKA activation
and AC activation could strongly control the steroid
response (steroid concentrations are states #39, 45-55)
by varying the cholesterol available to the inner mito-
chondria (Figure 3). Interestingly, enzyme mediated
reactions responsible for the conversion of cholesterol
to E2 and T were very robust to disturbances, making
them unlikely candidates for missing signaling regula-
tion elements. The sensitivity analysis for the model’s
nominal parameter set showed that steroidogenesis was
robust (weakly sensitive) to perturbation in the LH path-
way. Realizing that these results may be too strongly
dependent on the nominal parameter selection, the sen-
sitivity of each parameter was calculated for 1000 para-
meter generations, and analyzed for two different
scenarios: (1) which parameters most affected the
response of the entire steroidogenesis network (includ-
ing signaling components) (2) which parameters most
affected strictly the steroid trajectories (Figure 4). It is
clear from the resulting sensitivity distributions that
both the steroidogenesis network as a whole and specifi-
cally the steroid hormone profiles were most sensitive to
disturbances or regulation effecting PKA inhibition and
PKA translocation. Interestingly, the median of sensitiv-
ity of the steroid trajectories to PKA activation was sup-
pressed when compared to the sensitivity of the entire
network to PKA activation. Thus, sensitivity analysis
implicated that PKA inhibition and translocation
machinery were areas of interest when searching for
missing regulation.
Contrary to the sensitivity analysis, microarray data
suggested that mildly sensitive interactions were regu-
lated to manipulate and control the steroid response
during FAD stress. GO analysis showed several biologi-
cal processes specific to reproduction and oogenesis
were being modulated during stress, but the specific
effects of this modulation on steroid behavior are diffi-
cult to determine. Focusing on transcriptional regulation
observed within the ovary, LH receptor and P450
enzyme up-regulation and down-regulation of inhibin
transcription in vivo are possible modes of stress com-
pensation. By manipulating the corresponding para-
meters in the steroidogenesis model, each
transcriptional regulation event was evaluated for its
ability to explain over production of T and E2 during
depuration (Figure 6). Increasing the total concentration
of LH receptor resulted in over production of T and E2
during depuration, which was consistent with depura-
tion data (Figure 7A). Similar dynamics were observed
by manipulating the T regulation of LH mRNA tran-
scription. Neither the up-regulation of CYP17 nor the
down-regulation of inhibin had any effect on T and E2
production (Figure 7B and 7C).
Considering that both of these regulatory actions
simultaneously produced no effect on steroid produc-
tion, we hypothesize that the steroidogenesis network
has evolved a distributed compensation strategy to FAD
stress. Compensation is achieved by enhancing the sen-
sitivity to extra-ovary signals from the pituitary/hypotha-
lamus. This conclusion is further supported by in vitro
microarray data that shows no significant intra-ovary
regulation occurring (Additional File 1). This regulation
is not readily observable during exposure since the FAD
inhibition of aromatase activity dominates the network
compensation efforts. During depuration, after the FAD
stress has been removed, this regulation becomes appar-
ent as fish begin to over produce T and E2.
These results challenge the traditional technique of
employing sensitivity analysis to guide regulation discov-
ery. Generally, elements within a network considered
most sensitive are given priority during the next phase of
experimentation and regulation exploration. Microarray
data of the steroidogenesis network suggested that mildly
sensitive parameters, rather than highly sensitive ones,
were modulated during EDC stress response. This can be
rationalized by further examining the noise and crosstalk
that occurs in the G-protein, PKA, and AC cycles. Each
of these cycles is involved in several biological processes.
PKA is involved in the regulation of glyconeogenesis, gly-
colysis, and lipid metabolism [40] while the G-protein
and AC has been associated with a vast number of essen-
tial biological processes [41]. In the absence of noise,
these pathways can be manipulated to strongly control T
and E2 production, but the ability to control steroid
synthesis would be severely compromised by employing a
highly sensitive target which is exposed to a great deal of
cross-talk. The steroid network must balance sensitivity
with robustness to noise. A moderately sensitive target
which requires larger perturbations to account for
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cellular noise. Thus, in silico exploration for potential
regulation should consider targets that can effectively
manipulate the behavior of interest while remaining
robust to noise within the network.
Conclusions
Elucidating regulatory machinery in complex biological
systems can be aided by integrating heterogeneous data
into consistent, mathematical frameworks so that causal-
ity between genomic variation and the ensuing steroid
response can be examined. Furthermore, the implica-
tions of emergent properties, such as sensitivity and
robustness, can expedite the discovery of regulatory
mechanisms. Here, a signaling model of the FHM steroi-
dogenesis network consolidates regulation observed in
microarray data with its predicted effect on steroid pro-
duction. The model ultimately identifies LH receptor
regulation as a key compensation response to FAD
stress. This result goes against the more accepted sys-
tems approach in which the most sensitive interactions
are given priority in the search for undiscovered regula-
tion. However, the traditional approach does not con-
sider the significance of noise during regulation. Robust
regulation is a careful balance of efficacy versus resis-
tance to noise. The most sensitive interactions of the
FHM steroidogenesis network are known to be highly
communicative with other pathways, resulting in noisy
control. LH receptor is a better means of compensation
as hormone levels are highly regulated, guaranteeing
that any compensation response will be controllable,
though at the possible sacrifice of efficacy. In conclu-
sion, the model of FHM steroidogenesis allows for the
consolidation of genomic and physiological data, and
ultimately illustrates that target prioritization must con-
sider noise during discrimination.
Methods
Exposures
All fish used in the study were reproductively mature
female FHM (5-6 months old) obtained from an on-site
culture facility at the US EPA Mid-Continent Ecology
Division (Duluth, MN). All laboratory procedures invol-
ving animals were reviewed and approved by the Animal
Care and Use Committee in accordance with Animal
Welfare Act and Interagency Research Animal Commit-
tee guidelines.
Exposures for in vivo experiments were conducted in
20 L glass aquaria containing 10 L of UV treated, mem-
brane filtered, Lake Superior water containing nominal
concentrations of 0 or 50 μg/L FAD. All treatments
were delivered as a continuous flow through at a rate of
approximately 45 ml/min without the use of carrier
solvents. Toxicant (and control water) delivery was
initiated to four replicate tanks per treatment group
approximately 48 h prior to test initiation to ensure that
stable water concentrations were achieved before adding
fish. Exposures were then initiated by transferring ran-
dom groups of 6 female FHM to each tank. After 6, 12
and 24 hr of exposure, two fish from each of 4 replicate
tanks per treatment group were sampled (a total of 8
females per treatment per time point). During each sam-
pling period, the fish were euthanized in a buffered solu-
tion of tricaine methanesulfonate (MS-222; Finquel;
Argent, Redmond, WA, USA). Blood was collected
using heparinized microhematocrit tubes and plasma
was separated by centrifugation. A subsample of the
ovary was used for an ex vivo steroid production assay
(below). Plasma samples were stored at -80°C until
extracted and analyzed. Gonads, brain, and pituitary
were removed, snap frozen in liquid nitrogen, and
stored at -80°C until needed for RNA extraction.
Ex vivo steroid production assays were conducted
using methods adapted from McMaster et al. [42] as
described previously [39]. Subsamples of ovary were
transferred to glass test tubes containing 500 μl of Med-
ium 199 (M2520; Sigma, St. Louis, MO, USA) supple-
mented with 0.1 mM isobutylmethylxanthine (IBMX;
Sigma I7018) and 1 μg 25-hydroxycholesterol (Sigma)/
ml, on ice. At the end of each sample collection period,
the tubes were transferred to a 25°C shaker water bath
and incubated for 12 h. Following incubation, the med-
ium from each tube was collected and stored at -20°C
until analyzed and the tissue subsample from each tube
was removed and weighed. Tubes containing supple-
mented medium but no tissue were incubated, sampled,
a n da n a l y z e da l o n gw i t he x p e rimental samples to serve
as assay blanks.
In vitro exposures were conducted essentially as
described for ex vivo assays. Briefly, 12 female FHM
were euthanized as before and ovaries removed for in
vitro testing. For each exposure, ovaries from 6 replicate
fish were sliced into 12 ± 5 mg pieces and randomly dis-
tributed across sample culture wells to minimize sample
effects due to potential tissue heterogeneity. Ovary slices
were incubated in tissue culture medium supplemented
with IBMX (0.1 mM), 25-hydroxycholesterol (1 μg/ml),
and 50 uM FAD, or solvent control (0.07% methanol)
for 12 hrs. Replicate ovary slices were removed, snap
f r o z e ni nl i q u i dn i t r o g e n ,a n ds t o r e da t- 8 0 ° Cu n t i l
needed for RNA extraction. Medium from the incuba-
tions was used in analysis of E2 and T levels.
Steroids were extracted from medium samples (ex vivo
and in vivo) or plasma samples by liquid-liquid extrac-
tion with diethyl ether and then quantified by radio-
immunoassay [43].
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RNA was isolated from tissue using Qiagen RNAeasy™
kits according to the manufacturer’si n s t r u c t i o n s( Q i a -
gen, Valencia, CA). RNA integrity and quantity were
measured on an Agilent bioanalyzer (Agilent Technolo-
gies, Inc, Santa Clara, CA) and a nanodrop spectropho-
tometer (Nanodrop Technologies, Wilmington, DE),
respectively.
Microarray analysis
FHM 22,000 gene arrays (4 × 44 k format) were manu-
factured by Agilent and were purchased from EcoArray
(Alachua, FL). Array hybridizations were performed
u s i n gar e f e r e n c ed e s i g n ,w h e r ee a c hs a m p l ew a sc o m -
pared to a common reference sample. The reference
consisted of equal amounts of RNA from female and
male FHM tissues (liver, brain and gonad). Four repli-
cates consisting of four different individuals were ana-
lyzed for each of the treatments (24 hr FAD in vivo and
12 hr FAD in vitro along with corresponding controls).
cDNA synthesis, cRNA labeling and amplification and
hybridization were performed following the manufac-
turer’s kits and protocols (Agilent Low RNA Input
Fluorescent Linear Amplification Kit and Agilent 60-
mer oligo microarray processing protocol; Agilent, Palo
Alto, CA). Briefly, a primer containing poly dT and a
T7 polymerase promoter was added to 500 ng of total
RNA. Reverse transcriptase was added to the reaction to
synthesize the first and second strands of cDNA. Next,
cRNA was synthesized from the double-stranded cDNA
using T7 RNA polymerase, which simultaneously incor-
porates cyanine 3- (Cy3) or cyanine 5- (Cy5) labeled
CTP (Perkin-Elmer, Boston, MA). The ovary samples
were labeled with Cy5 while the reference sample was
labeled with Cy3. Once the labeling was complete, sam-
ples were hybridized to the microarray for 17 hours.
The microarrays were washed and scanned with a laser-
based detection system (Agilent, Palo Alto, CA).
MIAME compliant [44] text versions of microarray raw
data have been deposited at the Gene Expression Omni-
bus website [GEO: GSE15924].
Microarray image processing and data pre-processing
were performed using Agilent’s Feature Extraction soft-
ware v 9.5 (Agilent, 2007). The intensity of each spot
was summarized by the median pixel intensity. A log2
transformed signal ratio between the experimental chan-
nel and the reference channel was calculated for each
spot, followed by within array lowess transformation
and between array scale normalization on median inten-
sities. A two-way ANOVA was performed on log2 trans-
formed signal ratios of each probe individually, followed
by Tukey-HSD pair-wise comparisons to determine
genes whose expression is significantly regulated by the
treatments. Statistical significance was determined at a
p-value of < = 0.05 with a FDR threshold of 16%. FDR
was calculated using Benjamini-Hochberg approach [45].
Gene Ontology annotations were provided by EcoArray
Inc. based on sequence homologies between FHM array
probe target sequences and zebrafish, human and mouse
genes. Over representation of differentially expressed
genes in the biological process GO category was deter-
mined by Fisher Exact Test using a p-value < = 0.05 as
a significance level cutoff.
Steroidogenesis signaling model
The schematic of the steroidogenic signaling model is
shown in Figure 1. In the ovary, cholesterol uptake from
the outer mitochondrial membrane to the inner mito-
chondrial membrane is the rate limiting step. This
transport process is primarily regulated via the StAR
protein, which is in turn regulated by the LH pathway
[46]. LH is secreted from the pituitary, binds the LH
receptor in the theca cells of the ovary and activates the
G-protein cycle. G-protein activation initiates a cascade
of events, including adenylate cyclase (AC) activation,
cyclic AMP (cAMP) activation, protein kinase A (PKA)
activation, steroidogenic factor 1 (SF1) and StAR tran-
scription. A LH signaling framework for activation of
PKA has been reported by Bhalla and Hao et al. [34,47].
This framework was extended to describe the StAR pro-
tein activation via SF1. Cholesterol (Chol) uptake into
the inner mitochondrial membrane is regulated by StAR
protein and the concentration of cholesterol available to
the outer mitochondrial membrane and is described by
dC h o l i
dt
V
StARp
StARp StARp
Cholo
Kch Chol
km
ch
[] []
max
[]
[]
[
=
− +
−
0
1 C Choli].
(1)
The first term of the right hand side is responsible for
cholesterol uptake into the inner mitochondrial mem-
brane and second term is the subsequent consumption
of inner mitochondrial cholesterol by steroid synthesis.
The expression of SF1 and activated SF1 was consid-
ered comparable to cAMP’sa c t i v a t i o no fC R E Bp r o t e i n ,
as reported by Hao et al. [34]. Also, similar kinetic
descriptions reported for per gene transcription and
translation were applied to StAR mRNA and StAR pro-
tein synthesis.
The LH signaling architecture was coupled with the
steroidogenesis enzymatic network established by Breen
et al. [24], where cholesterol is utilized for synthesis of
subsequent steroid products. It is assumed that T, AD,
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plasma with the following kinetic descriptions:
dA D ex
dt
km AD
[]
[] = 18 (2)
dEex
dt
km E
[]
[]
1
1 19 = (3)
dT ex
dt
km T
[]
[] = 10 (4)
dE ex
dt
km E
[]
[]
2
2 14 = (5)
A number of EDCs can inhibit steroidogenic enzymes.
The predictive power of the model is tested by stressing
ovary cells with FAD. FAD is a specific competitive inhi-
bitor of aromatase (CYP19), which catalyzes two impor-
tant steroidogenic metabolic reactions: AD to E1 and T
to E2 [24,48]. FAD diffuses into the ovary and maintains
equilibrium with medium as:
dF A D
dt
km FAD km FAD ex
[]
[] [ ] . =− 15 20 (6)
FADex is FAD concentration in the bloodstream/
plasma and FAD is the concentration in the ovary. Para-
meter km15 is the partition coefficient constant and
km20 is the first order diffusion constant from the ovary
to the medium. The FAD inhibition is incorporated by
modulating the kinetic parameters responsible for the
conversion of AD to E1 and T to E2.( S e eA d d i t i o n a l
files 2, 3, 4 for a list of all ODEs, parameters and para-
meter information).
E2 and T are circulated to other steroidogenic organs
by the blood stream. LH is secreted from pituitary and
controlled by Gonadotropin-releasing hormone. LH
release is further regulated, via negative feedback, by T
and E2 [49-54]. This regulation is lumped into a module
labeled signaling modulation since a more detailed model
of the pituitary and hypothalamus are not available at
this time. GnRH, E2 and T feedback is described as
dL m
dt
V
GnRH n
KcpLH GnRH n Tex
KinLH
E ex
KinLH
spLH
[] [ ]
[] [] [ ]
=
++ +
2 2 2
− −
+
− V
Lm
KmpLH Lm
KL mpLH dmpLH m
[]
[]
[]
(7)
where Lm is the amount of LH mRNA. GnRH is modeled
as a pulsatile forcing function with a magnitude of 10 nM
and a 30 minute pulse occurring one time per hour.
Parameter selection
Parameters k1 through k60 and parameters for StAR
mRNA, StAR protein, LH mRNA and LH protein were
obtained from Hao et al [34]. Half of the parameters
specific to the enzyme-mediated conversion of choles-
terol to its derivatives (km9, km10, ... km20)a r ef r o ma n
in vitro study of ovarian steroidogenesis [24]. During
data analysis, concentrations of the sex steroids within
1 - 2 nM are observed. A flux balance analysis (FBA)
was performed to predict the unmeasured, intermediate
steroids concentrations. The analysis was performed
such as to maximize T and E2 production (See Addi-
tional File 5). The remaining parameters were tuned to
achieve the steroid response observed when fish were
exposed to 50 μg/L FAD for 24 hours (See Figure 2),
and to match the intermediate steroid profiles predicted
b yt h eF B A .C a r ew a st a k e nt oe n s u r et h ep a r a m e t e r
values were on the order of those observed in the Breen
et al. [24] model. Initial conditions for an unexposed
FHM were established by determining the steady state
of the system applying the initial conditions from [34]
with the additional constraint of a concentration of
60,000 nM cholesterol outside of the mitochondria. The
resulting steady state values are in Additional File 6. Dif-
ferential equations were solved using the MATLAB stiff
ODE integrator ode15s. It should be noted that stiffness
was not an issue while simulating the nominal model.
Sensitivity analysis
Sensitivity is the response of a state trajectory to infini-
tesimal perturbations in parameter values, and this mea-
sure is normalized by the size of the state and
parameter so that comparisons between states can be
made. For a lumped system model described by
 xf x p = (,) , the relative sensitivity is defined as:
S
dx
dp
p
x
dx
dp
∧
=× =
ln( )
ln( )
(8)
where x is the state vector and p is the parameter vec-
tor. Sensitivity is calculated using finite differences.
Sensitivity is a local measure whose results may be
highly dependent on the choice of nominal parameters.
To approximate a semi-global understanding of the
effects of parameter variability on the steroid response,
the relative sensitivity was calculated for each state to
each parameter included in the steroidogenesis model
for 1000 parameter generations. Each parameter genera-
tion was created by sampling a relative perturbation
value from a normal distribution centered about zero
with a standard deviation of 10.0%. For each generation,
114 perturbations were sampled from the distribution
and applied in a multiplicative fashion to each of the
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eration j is ki,j = ki*(1 + δj) where δj is the perturbation).
The initial conditions for each calculation are the same
as those applied for the nominal model. Each sensitivity
trajectory was calculated over a span of 30 days. Figure
3 shows the sensitivity of each state to each parameter,
averaged over time, for a single generation.
A boxplot was used to demonstrate the robustness of
the results of Figure 3. Boxplots illustrate statistical
differences between competing hypotheses. Referring to
Figure 4, the lower, middle-lower, middle-upper, and
upper boxes represent the lower quartile, mid-lower
quartile, mid-upper quartile, and upper quartile of a dis-
tribution. For each parameter, the sensitivity of that para-
meter is averaged over time and states for each
generation, resulting in 1000 average relative sensitivity
(ARS) values for each parameter. The boxplots illustrate
how the ARS is distributed for each parameter. The red
bar represents the median ARS for each parameter. If the
notches about the median of two parameters do not
overlap, one can conclude with 95% confidence that the
true medians differ. Figure 4 shows two scenarios. The
top is when the sensitivity of all states is considered dur-
ing averaging. The bottom is when only chol and steroid
concentrations are considered. It is known that, in biolo-
gical systems, parameter values may fluctuate over orders
of magnitude, but discretization issues and stiffness aris-
ing in particular parameter generations made it difficult
to consider larger uncertainty ranges in a timely manner.
The distributions of the ARS showed that parameter
rankings (most sensitive versus least sensitive) were well
maintained despite changes to parameter value, and pre-
vious studies have shown similar conclusions [14,15,55]
Simulation studies
Expression variation observed in microarray data was
simulated to predict the effect of transcriptional regula-
tion on protein behavior. It is not safe to assume that
up or down genomic regulation translates linearly with
the corresponding protein concentration. The affect of
each gene on steroidogenic behavior is evaluated by per-
turbing the corresponding enzyme concentration (or
activity) in the direction of the reported regulation over
several orders of magnitude. We used as a control the
simulation results of an unexposed fish. The initial con-
centration of LH receptor was multiplied by dimension-
less perturbations of [10
1,1 0
2,1 0
3]t os i m u l a t eL H
receptor up regulation (Figure 7A). Cytochrome
P450c17ahydroxylase/17,20 lyase, identified as up regu-
lated in microarray data, impacted the conversion rates,
k5 and k7, respectively. Both were multiplied by order of
magnitude perturbations, [10
1,1 0
2,1 0
3] dimensionless.
Inhibin down regulation was achieved by multiplying
the maximum inhibin production rate (Vspin)b yo r d e r
of magnitude perturbations [10
-1,1 0
-2,1 0
-3] dimension-
less units (Figure 7C).
Additional material
Additional file 1: Functional Gene Ontology analysis of genes
differentially expressed in ovaries during fadrozole exposure. A list
of all significantly enriched Gene Ontology (GO) categories from in vitro
exposures of ovary slices and in vivo exposures of ovaries to fadrozole.
This list contains the number of genes selected, the number of genes on
the array, the Fisher p Value, and the false discovery rate for each GO
category.
Additional file 2: Chemical Species of the Steroidogenesis Model.A
list and full definition of all chemical species used in the modeling
annotation of the Steroidogenesis Model.
Additional file 3: Rate equations for ovarian steroidogenesis.A
complete listing of all 55 rate equations used in development of the
steroidogenesis model.
Additional file 4: Steroidogenesis Model Parameters. A complete
listing of parameters, parameter descriptions, parameter units and values
used in development of the Steroidogenesis model.
Additional file 5: Flux balance analysis of ovarian steroidogenesis
model. This file describes how Flux Balance Analysis was conducted.
Additional file 6: Initial model conditions. This file describes the initial
condition values for each variable within the model.
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